The FDA accepted the supplemental new drug application (sNDA) for aminolevulinic acid hydrochloride 10% topical gel (Ameluz) as part of photodynamic therapy (PDT) for superficial basal cell carcinoma ...
Bavarian Nordic A/S ADR company and executive profile by Barron's. View the latest BVNRY company infomation and executive bios.
The dedicated ultra-runner is one of very few to have made it through a full two years of an innovative cancer treatment, ...
A book detailing a cancer journey that started in 2020 is a former country footballer’s latest attempt to raise funds for a ...
Atomically engineered nanozymes (AENs) combine precise nanotechnology with catalytic functions to enhance immune regulation through atomic-level ...
Cervical screening for women and people with a cervix aged 25–64 – you will be invited every 5 years to check the health of your cervix. Cervical screening used to be called a smear test. Lung cancer ...
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's ...
ABSTRACT: Since long surgical excision of the tumors, followed by anti-cancer therapy, and irradiation were the basic tenets of management of all malignancies. Recently, Dendritic Cells (DCs) therapy ...
Lawrence Fong M.D. ’92, the scientific director of the Fred Hutch Cancer Center’s Immunotherapy Integrated Research Center (IIRC), discussed his lab’s latest innovations in cancer immunotherapy in a ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation ...
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Two new studies, published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results